Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ANTX
CHRS
Add up to 3 more stocks
ANTX
AN2 Therapeutics, Inc.
-9.67%
$5.07-0.54Delayed quote: Oct 6, 2026, 1:24 PM EDT
Market Cap
$182.51M
52W Range
$1.00 - $7.19
CHRS
Coherus Oncology, Inc.
-8.04%
$1.03-0.09Delayed quote: Oct 6, 2026, 1:20 PM EDT
Market Cap
$159.14M
52W Range
$1.08 - $2.62
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.40 | 2.62 |
| P/S Ratio | N/A | 3.12 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 63.5% |
| Operating Margin | 0.0% | -425.7% |
| Net Margin | 0.0% | -257.1% |
| ROE | -47.8% | -215.3% |
| ROA | -44.4% | -68.5% |
| ROIC | -51.0% | -135.4% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 14.32 | 1.77 |
| Quick Ratio | 14.32 | 1.70 |
| Debt/Equity | 0.00 | 0.62 |
| Interest Coverage | N/A | -19.95 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.